CRISPR Therapeutics AG ($CRSP) Stock Forecast: Down 5.0% Today

What is CRISPR Therapeutics AG?

CRSP (CRISPR Therapeutics AG) is a biotechnology company specializing in gene-based medicines. The overall market saw gains today, but CRSP had a bearish movement.

Why is CRISPR Therapeutics AG going down?

CRSP stock is down 5.0% on Nov 10, 2025 15:40

• CRSP stock dropped by -2.56% despite overall market gains.
• The bearish movement may be due to profit-taking by investors after a growth period.
• Concerns about the company's future earnings potential or regulatory challenges could be influencing investors.
• Monitoring upcoming developments in the biotech sector that could affect CRSP's stock performance is important.

CRSP Price Chart

CRSP Technical Analysis

CRSP News

CRISPR Therapeutics AG ( CRSP ) Stock Drops Despite Market Gains: Important Facts to Note

The latest trading day saw CRISPR Therapeutics AG (CRSP) settling at $55.16, representing a -2.56% change from its previous close.

https://www.zacks.com/stock/news/2788121/crispr-therapeutics-ag-crsp-stock-drops-despite-market-gains-important-facts-to-note

Trending Today

Ethereum ($ETH) Crypto Forecast: Down 5.1% Today

CRISPR Therapeutics AG Price History

10.09.2025 - CRSP Stock was down 5.1%

• CRSP stock saw a significant bearish movement, dropping by 6.98% to close at $67.74.
• The stock's decline was more pronounced than the broader market trend, indicating specific factors impacting CRISPR Therapeutics AG.
• The dip in CRSP stock could be attributed to potential concerns over the company's research and development pipeline or general market volatility affecting biotech stocks.
• Investors may be closely monitoring any updates on CRISPR Therapeutics' clinical trials, regulatory approvals, or competitive landscape to gauge the stock's future performance.

31.09.2025 - CRSP Stock was up 5.8%

• Despite a -2.51% change from the previous close, the market movement for CRSP today was bullish.
• The slight decrease in stock price may be due to profit-taking by some investors following a recent uptrend.
• Positive sentiment towards the company's gene-editing technology and future growth prospects likely fueled the bullish movement.
• Investors' optimism about CRSP's pipeline of gene therapies and their potential to address unmet medical needs could be boosting the stock price.

18.08.2025 - CRSP Stock was up 6.2%

• Despite falling more steeply than the broader market in the previous trading session, CRSP closed with a significant bullish movement today.
• The -3.46% move from the previous day might have been a temporary correction or profit-taking by some investors.
• The bullish movement today could be attributed to positive factors like a successful clinical trial, a new partnership, or overall market optimism towards the biotechnology sector.
• Investors in CRSP need to stay updated with the latest developments in the company and the broader biotech industry to make informed decisions.

05.07.2025 - CRSP Stock was down 5.2%

• CRISPR Therapeutics (CRSP) stock closed at $56.26 today, showing a bearish movement of -2.46% from the previous trading day.
• The decline in CRSP stock price is linked to the company's wider second-quarter loss, mainly due to expenses related to the Sirius deal.
• Investors may view the company's emphasis on increasing Casgevy adoption as a risky move amidst current market conditions.
• Market sentiment towards CRSP appears more negative compared to the broader market, reflecting specific concerns about the company's financial performance and strategic choices.

04.07.2025 - CRSP Stock was up 5.7%

• Despite a recent slight decline in trading, CRSP demonstrated strong bullish movement overall.
• Some investors engaged in profit-taking, causing a temporary dip in CRSP's stock price following a period of significant growth.
• The positive momentum in CRSP is likely fueled by advancements in the company's gene-based medicine portfolio, driving up investor confidence.
• While a general market decline had a limited impact on CRSP's stock price, the prevailing positive outlook on the company remains steadfast.

06.09.2025 - CRSP Stock was up 5.0%

• Factors contributing to the rise in CRSP stock today include:
• Despite a recent stock decline, the overall market trend indicates investor optimism towards the future of CRISPR Therapeutics AG.
• The -6.98% change from the previous close could be a temporary adjustment, presenting an opportunity for investors interested in benefiting from the decrease.
• It's important for investors to monitor developments in the CRISPR technology sector closely, as progress or regulatory authorizations could have a significant impact on CRSP stock in the future.

22.09.2025 - CRSP Stock was down 6.3%

• Today's downward trend in CRSP stock could be linked to profit-taking by investors following a recent uptick in its price.
• The -2.24% drop might also be influenced by broader market sentiments or shifts within the biotech sector.
• Investor reactions may be tied to potential negative updates or uncertainties surrounding the company's clinical trials, regulatory challenges, or competitive landscape in gene editing.
• It is crucial for investors to stay informed about the company's pipeline progress and regulatory changes to evaluate the future trajectory of CRSP stock.

29.06.2025 - CRSP Stock was down 7.5%

• Investor caution may be linked to CRISPR Therapeutics' upcoming Q2 earnings report, with focus on Casgevy sales growth and advancements in its gene-editing pipeline.
• The decline in stock value could stem from traders taking profits, particularly following a recent market uptrend, suggesting a short-term adjustment.
• Market dynamics may also be influenced by general market trends or industry-specific developments affecting biotechnology stocks, contributing to the bearish sentiment surrounding CRSP today.

10.10.2025 - CRSP Stock was down 5.0%

• CRSP stock dropped by -2.56% despite overall market gains.
• The bearish movement may be due to profit-taking by investors after a growth period.
• Concerns about the company's future earnings potential or regulatory challenges could be influencing investors.
• Monitoring upcoming developments in the biotech sector that could affect CRSP's stock performance is important.

16.08.2025 - CRSP Stock was up 5.3%

• Factors contributing to the bullish movement in CRSP stock today include:
• The bullish trend in the market prompting investors to purchase CRSP despite a minor decline in the previous trading session.
• Positive news or advancements in CRSP's gene editing technologies or pipeline boosting investor confidence.
• Strong financial performance and positive future outlook attracting more buyers.
• Possible partnerships or collaborations in the biotech sector involving CRSP piquing investor interest and driving up the stock price.

30.08.2025 - CRSP Stock was up 5.7%

• CRISPR Therapeutics AG (CRSP) saw a strong bullish movement today, closing at $61.67, with a +2.24% increase from the previous day.
• This positive momentum could be linked to successful clinical trial outcomes or regulatory clearances related to their gene therapies, fueling optimism among investors regarding the company's future.
• Amidst this upward trend, staying abreast of any potential market fluctuations or regulatory hurdles that may affect CRISPR Therapeutics AG (CRSP) going forward is crucial for investors.

14.09.2025 - CRSP Stock was down 10.4%

• CRSP stock saw a more significant decline compared to the broader market, ending at $68.29, reflecting a -6.54% change from the previous day, indicating a bearish trend.
• The stock's notable drop could be linked to profit-taking activities by investors following a recent price surge or concerns regarding the company's pipeline or financial results.
• Despite the market's positive performance, specific internal factors within CRSP such as regulatory challenges, clinical trial outcomes, or alterations in analyst outlooks might have influenced its stock decline.
• Investors are likely keeping a close watch on developments in the biotech industry and updates on CRISPR technology that could impact CRSP's stock movement in the near future.